FDA green lights stem cell clinical trial for Lou Gehrig’s disease
“The Rockville, Maryland based company Neuralstem has received US Food and Drug Administration (FDA) permission to test its spinal...“The Rockville, Maryland based company Neuralstem has received US Food and Drug Administration (FDA) permission to test its spinal cord stem cells in twelve patients with amyotrophic lateral sclerosis, or Lou Gehrig’s disease. The approval comes a month after the FDA placed Geron’s planned clinical trial on hold for a second time. Neuralstem’s trial had also previously been placed on hold by the FDA in February before it received the go-ahead in September.”